Healthcare

In 2014, the Australian aged care market was worth A$14 billion and is expected to grow at an annual rate of four per cent for the next five years (2015-2020). Of the total market, A$9.5 billion was provided by the federal government, while the remainder of A$4.5 billion was privately funded by companies and residents. Australian aged care systems ...

Drug-resistant bacteria, or superbugs, pose a serious threat to human health. Developing new antibacterial drugs requires a great deal of time, effort, expenditure, and scientific research, making it a less-attractive segment for investment by pharmaceutical companies. This research service focuses on the global antibacterial drugs (antibiotics) ma...

The research service assesses marketed and investigational products, as well as combination regimens, for asthma and chronic obstructive pulmonary disease (COPD). Segmentation by drug class is provided along with additional supporting information such as clinical trial timelines and results, historical and projected launch timelines, and epidemiolo...

This research service presents an overview and analysis of the contract research organization (CRO) market. It provides revenue forecasts for the CRO market by phase and therapeutic type. The study discusses the key challenges, unmet needs, and emerging trends in the market and. It covers the complete life cycle of the CRO industry, starting from p...

This study assesses marketed and in-research products and combination regimens for the lung cancer therapeutics market. Segmentation by drug class is provided, along with additional supporting information such as clinical trial timelines and results, historical and projected launch timelines, and epidemiology. The marketed and pipeline products are...

Vaccines represent a class of biologics that are administered to prevent infectious diseases to reduce mortality and morbidity. It is estimated that the introduction of vaccines has reduced the incidence of various diseases by greater than 90%. This study examines the global vaccines market, including marketed products and products under clinical d...

The pharmaceutical industry in Ghana and Nigeria is forecast to represent a combined business opportunity of over $3 billion by 2018, propelled by a convergence of changing economic profiles, increased healthcare spending and investment, and increasing incidence of chronic diseases. Market segmentation is done based on products (OTC, generic, and b...

Mobile Health or mHealth includes all products and services that leverage mobile communication technologies to deliver healthcare services. Current research scope includes mobile apps and services but not devices. Our study found that while patients and consumers in Australia are ready to adopt mHealth, clinicians are apprehensive about the quality...

Temporomandibular Disorder (TMD) is a complex condition that affects the temporomandibular joint (TMJ), the joint connecting the lower jaw to the skull. About 50% of the patient population receiving treatment for TMD complains of pain after 5 years of treatment, and about 20% of the population experiences long-term disability. Estimated annual heal...